Aclaris Therapeutics (ACRS) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of$0.28. This compares to loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 14.29$0.37 per share when it actually produced a loss of $0.30, delivering a surprise of 18.92%. Over the last four qu ...